Biblio

Author Title Type [ Year

]

Filters: Author is Yang, Yi [Clear All Filters]

2024

Chen Z, Xia X, Yao M, Yang Y, Ao X, Zhang Z, Guo L, Xu X. The dual role of mesenchymal stem cells in apoptosis regulation. Cell Death Dis. 2024;15(4):250.

Wang S, He Q, Qu Y, Yin W, Zhao R, Wang X, Yang Y, Guo Z-N. Emerging strategies for nerve repair and regeneration in ischemic stroke: neural stem cell therapy. Neural Regen Res. 2024;19(11):2430-2443.

Luo F, Zhang M, Sun B, Xu C, Yang Y, Zhang Y, Li S, Chen G, Chen C, Li Y, et al. LINC00115 promotes chemoresistant breast cancer stem-like cell stemness and metastasis through SETDB1/PLK3/HIF1α signaling. Mol Cancer. 2024;23(1):60.

2023

Varlı M, Lee E-Y, Yang Y, Zhou R, Taş İ, Pulat S, Gamage CDB, Park S-Y, Hur J-S, Nam S-J, et al. 1'-O-methyl-averantin isolated from the endolichenic fungus Jackrogersella sp. EL001672 suppresses colorectal cancer stemness via sonic Hedgehog and Notch signaling. Sci Rep. 2023;13(1):2811.

Xiao H, Wang S, Tang Y, Li S, Jiang Y, Yang Y, Zhang Y, Han Y, Wu X, Zheng L, et al. Absence of terminal deoxynucleotidyl transferase expression in T-ALL/LBL accumulates chromosomal abnormalities to induce drug resistance. Int J Cancer. 2023.

Gao X, Hu X, Yang D, Hu Q, Zheng J, Zhao S, Zhu C, Xiao X, Yang Y. Acoustic quasi-periodic bioassembly based diverse stem cell arrangements for differentiation guidance. Lab Chip. 2023.

Yang Y, He L, Xie Y, Zhu L, Wu J, Fan Y, Yang Y, Sun X. correction of various β-thalassemia mutations in human hematopoietic stem cells. Front Cell Dev Biol. 2023;11:1276890.

Yang Y, Wang S, Cai J, Liang J, Zhang Y, Xie Y, Luo F, Tang J, Gao Y, Shen S, et al. Correction: Targeting ARHGEF12 promotes neuroblastoma differentiation, MYCN degradation, and reduces tumorigenicity. Cell Oncol (Dordr). 2023.

Cheng Y, Xiao Y, Ruan Y, Wang J, Tian Y, Xiong J, Wang J, Wang F, Zhang C, Xu Y, et al. Corrigendum to "Comparative expression analysis of TEADs and their splice variants in mouse embryonic stem cells" [Gene Expr Patterns 47 (2022) 119302/36516960]. Gene Expr Patterns. 2023;49:119332.

Wu W, Ding S, Mingming Z, Yuping Z, Sun X, Zhao Z, Yang Y, Hu Y, Dong H. Cost effectiveness analysis of CAR-T cell therapy for patients with relapsed/refractory multiple myeloma in China. J Med Econ. 2023:1-15.

Sharma A, Boelens J-J, Cancio M, Hankins JS, Bhad P, Azizy M, Lewandowski A, Zhao X, Chitnis S, Peddinti R, et al. CRISPR-Cas9 Editing of the and Promoters to Treat Sickle Cell Disease. N Engl J Med. 2023;389(9):820-832.

Liu X-S, Yuan L-L, Gao Y, Ming X, Zhang Y-H, Zhang Y, Liu Z-Y, Yang Y, Pei Z-J. DARS2 overexpression is associated with PET/CT metabolic parameters and affects glycolytic activity in lung adenocarcinoma. J Transl Med. 2023;21(1):574.

Ji Y, Zhang W, Shen K, Su R, Liu X, Ma Z, Liu B, Hu C, Xue Y, Xin Z, et al. The ELAVL3/MYCN positive feedback loop provides a therapeutic target for neuroendocrine prostate cancer. Nat Commun. 2023;14(1):7794.

Chen Z, Yao M-W, Ao X, Gong Q-J, Yang Y, Liu J-X, Lian Q-Z, Xu X, Zuo L-J. The expression mechanism of programmed cell death 1 ligand 1 and its role in immunomodulatory ability of mesenchymal stem cells. Chin J Traumatol. 2023.

Wang W, Li X, Qin X, Miao Y, Zhang Y, Li S, Yao R, Yang Y, Yu L, Zhu H, et al. Germline Neurofibromin 1 mutation enhances the anti-tumour immune response and decreases juvenile myelomonocytic leukaemia tumourigenicity. Br J Haematol. 2023.

Liu L, Zhang J, Wang J, Tian Y, Wang J, Xu Y, Cheng Y, Yu M, Wang J, Yang Y, et al. Identification and functional comparison of novel alternatively spliced isoforms of human YAP. FEBS Open Bio. 2023.

Wang J, Huang Y, Zhang C, Ruan Y, Tian Y, Wang F, Xu Y, Yu M, Wang J, Cheng Y, et al. Identification and functional evaluation of alternative splice variants of Dax1 in mouse embryonic stem cells. Stem Cells Dev. 2023.

Wu X, Jiang D, Yang Y, Li S, Ding Q. Modeling drug-induced liver injury and screening for anti-hepatofibrotic compounds using human PSC-derived organoids. Cell Regen. 2023;12(1):6.

Ruan Y, Wang J, Yu M, Wang F, Wang J, Xu Y, Liu L, Cheng Y, Yang R, Zhang C, et al. A multi-omics integrative analysis based on CRISPR screens re-defines the pluripotency regulatory network in ESCs. Commun Biol. 2023;6(1):410.

Wang J, Zhang C, Huang Y, Ruan Y, Hu Y, Wang J, Wang F, Yu M, Xu Y, Liu L, et al. Parallel genome-wide CRISPR screens to identify state-dependent self-renewal regulators of mouse embryonic stem cells. Stem Cells Dev. 2023.

Xu H-J, Liu X-Z, Yang L, Ning Y, Xu L-L, Sun D-M, Liao W, Yang Y, Li Z-H. Runx2 overexpression promotes bone repair of osteonecrosis of the femoral head (ONFH). Mol Biol Rep. 2023.

Zhang Y-H, Liu X-S, Gao Y, Yuan L-L, Huang Z-M, Zhang Y, Liu Z-Y, Yang Y, Liu X-Y, Bin Ke C-, et al. SFXN1 as a potential diagnostic and prognostic biomarker of LUAD is associated with F-FDG metabolic parameters. Lung Cancer. 2023;188:107449.

Shi Q, Yu B, Zhang Y, Yang Y, Xu C, Zhang M, Chen G, Luo F, Sun B, Yang R, et al. Targeting TRIM24 promotes neuroblastoma differentiation and decreases tumorigenicity via LSD1/CoREST complex. Cell Oncol (Dordr). 2023.

Cai F, Song B, Yang Y, Liao H, Li R, Wang Z, Cao R, Chen H, Wang J, Wu Y, et al. USP25 contributes to defective neurogenesis and cognitive impairments. FASEB J. 2023;37(6):e22971.

Wu W, Zhou Y, Wang Y, Keramat SAfroz, Balasooriya NN, Zhao Z, Yang Y, Comans T, Dong H. Value for Money of CAR-T Cell Therapy for Patients with Diffuse Large B-cell Lymphoma in China: Evidence from a Cost-Effectiveness Analysis. Appl Health Econ Health Policy. 2023.

Pages